Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Head & Neck
|
July 14, 2016
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma
Robert H I Andtbacka, Sanjiv S Agarwala, David W Ollila, et al.
American Journal of Public Health
|
October 28, 2021
Establishment and Evaluation of a Large Contact-Tracing and Case Investigation Virtual Training Academy
Olivia Golston, Michael Prelip, Debbie Bain Brickley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 7, 2026
A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit
Jessica G H Bruystens, Jian Wu, Gerald Tan, et al.
Frontiers in Immunology
|
December 30, 2022
Proteogenomic identification of Hepatitis B virus (HBV) genotype-specific HLA-I restricted peptides from HBV-positive patient liver tissues
Mayank Srivastava, Richard Copin, Augustine Choy, et al.
Biorxiv : the Preprint Server for Biology
|
January 3, 2024
Molecular Determinants and Signaling Effects of PKA RIα Phase Separation
Julia C Hardy, Emily H Pool, Jessica G H Bruystens, et al.
Molecular Cell
|
March 27, 2024
Molecular determinants and signaling effects of PKA RIα phase separation
Julia C Hardy, Emily H Pool, Jessica G H Bruystens, et al.
Frontiers in Public Health
|
August 26, 2021
California's COVID-19 Virtual Training Academy: Rapid Scale-Up of a Statewide Contact Tracing and Case Investigation Workforce Training Program
Debbie B Brickley, Maeve Forster, Amelia Alonis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2017
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
Jason Chesney, Igor Puzanov, Frances Collichio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2014
Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer
Eric Van Cutsem, Cathy Eng, Elzbieta Nowara, et al.
Cell
|
August 11, 2018
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas, Reinhard Dummer, Igor Puzanov, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Head & Neck
|
July 14, 2016
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma
Robert H I Andtbacka, Sanjiv S Agarwala, David W Ollila, et al.
American Journal of Public Health
|
October 28, 2021
Establishment and Evaluation of a Large Contact-Tracing and Case Investigation Virtual Training Academy
Olivia Golston, Michael Prelip, Debbie Bain Brickley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 7, 2026
A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit
Jessica G H Bruystens, Jian Wu, Gerald Tan, et al.
Frontiers in Immunology
|
December 30, 2022
Proteogenomic identification of Hepatitis B virus (HBV) genotype-specific HLA-I restricted peptides from HBV-positive patient liver tissues
Mayank Srivastava, Richard Copin, Augustine Choy, et al.
Biorxiv : the Preprint Server for Biology
|
January 3, 2024
Molecular Determinants and Signaling Effects of PKA RIα Phase Separation
Julia C Hardy, Emily H Pool, Jessica G H Bruystens, et al.
Molecular Cell
|
March 27, 2024
Molecular determinants and signaling effects of PKA RIα phase separation
Julia C Hardy, Emily H Pool, Jessica G H Bruystens, et al.
Frontiers in Public Health
|
August 26, 2021
California's COVID-19 Virtual Training Academy: Rapid Scale-Up of a Statewide Contact Tracing and Case Investigation Workforce Training Program
Debbie B Brickley, Maeve Forster, Amelia Alonis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2017
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
Jason Chesney, Igor Puzanov, Frances Collichio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2014
Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer
Eric Van Cutsem, Cathy Eng, Elzbieta Nowara, et al.
Cell
|
August 11, 2018
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas, Reinhard Dummer, Igor Puzanov, et al.
Page
of 6